Drug use and opioid substitution treatment for prisoners

被引:51
|
作者
Stoever, Heino [1 ]
Michels, Ingo Ilja [2 ]
机构
[1] Univ Appl Sci, Res Inst Addict, D-60318 Frankfurt, Germany
[2] Deutsch Gesell Tech Zusammenarbeit GTZ, Cent Asia Drug Act Programme CADAP European Union, Bishkek, Kyrgyzstan
关键词
METHADONE-MAINTENANCE TREATMENT; RANDOMIZED CONTROLLED-TRIAL; HEPATITIS-C; BUPRENORPHINE; TRANSMISSION; RISK; HIV; ATTITUDES; INJECTION;
D O I
10.1186/1477-7517-7-17
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Drug use is prevalent throughout prison populations, and, despite advances in drug treatment programmes for inmates, access to and the quality of these programmes remain substantially poorer than those available for non-incarcerated drug users. Because prisoners may be at greater risk for some of the harms associated with drug use, they deserve therapeutic modalities and attitudes that are at least equal to those available for drug users outside prison. This article discusses drug use by inmates and its associated harms. In addition, this article provides a survey of studies conducted in prisons of opioid substitution therapy (OST), a clinically effective and cost-effective drug treatment strategy. The findings from this overview indicate why treatment efforts for drug users in prison are often poorer than those available for drug users in the non-prison community and demonstrate how the implementation of OST programmes benefits not only prisoners but also prison staff and the community at large. Finally, the article outlines strategies that have been found effective for implementing OST in prisons and offers suggestions for applying these strategies more broadly.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Illicit drug use in Queensland women prisoners
    Turner, C
    Hockings, B
    Falconer, T
    O'Rourke, P
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH, 2004, 28 (04) : 390 - 391
  • [32] Predictors of Illicit Drug Use Among Prisoners
    Rowell-Cunsolo, Tawandra L.
    Sampong, Stephen A.
    Befus, Montina
    Mukherjee, Dhritiman V.
    Larson, Elaine L.
    SUBSTANCE USE & MISUSE, 2016, 51 (02) : 261 - 267
  • [33] Drug use and perceived treatment need among newly sentenced prisoners in England and Wales
    Stewart, Duncan
    ADDICTION, 2009, 104 (02) : 243 - 247
  • [34] Continuous opioid substitution treatment over five years: Heroin use trajectories and outcomes
    Eastwood, Brian
    Strang, John
    Marsden, John
    DRUG AND ALCOHOL DEPENDENCE, 2018, 188 : 200 - 208
  • [35] Buprenorphine oral lyophilisate (Espranor®) in the substitution treatment of opioid dependence: a profile of its use
    Lyseng-Williamson K.A.
    Drugs & Therapy Perspectives, 2017, 33 (6) : 241 - 248
  • [36] Self-perceived problem with alcohol use among opioid substitution treatment clients
    Islam, M. Mofizul
    Day, Carolyn A.
    Conigrave, Katherine M.
    Topp, Libby
    ADDICTIVE BEHAVIORS, 2013, 38 (04) : 2018 - 2021
  • [37] Urine Drug Screening in a Telehealth Setting for the Treatment of Opioid Use Disorder
    Williams, Arthur Robin
    Rowe, Christopher
    Gallagher, Ryan
    Aronowitz, Shoshana V.
    Diamond-Reivich, Jon
    Bisaga, Adam
    JAMA HEALTH FORUM, 2023, 4 (07):
  • [38] Prescription drug use among pregnant women in opioid Maintenance Treatment
    Lund, Ingunn Olea
    Skurtveit, Svetlana
    Engeland, Anders
    Furu, Kari
    Ravndal, Edle
    Handal, Marte
    ADDICTION, 2013, 108 (02) : 367 - 376
  • [39] Drug Screening Tests Improve Treatment Retention in a Cohort of Outpatients Starting Opioid Substitution Therapy
    Dupouy, Julie
    Dassieu, Lise
    Bourrel, Robert
    Poutrain, Jean Christophe
    Bismuth, Serge
    Oustric, Stephane
    Lapeyre-Mestre, Maryse
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 312 - 313
  • [40] Nutritional Implications of Opioid Use Disorder: A Guide for Drug Treatment Providers
    Chavez, Melody N.
    Rigg, Khary K.
    PSYCHOLOGY OF ADDICTIVE BEHAVIORS, 2020, 34 (06) : 699 - 707